Estrella Immunopharma, Inc. (ESLA) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-21 | 8-K | Listing Notice | SEC |
| 2026-06-30 | 8-K | Shareholder Vote Results | SEC |
| 2026-01-13 | 8-K | Listing Notice | SEC |
| 2026-01-06 | 8-K | Material Agreement, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-04 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-11-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-29 | 8-K | Other Events | SEC |
| 2025-09-26 | 8-K | Officer / Director Changes | SEC |
| 2025-08-07 | 8-K | Listing Notice | SEC |
| 2025-06-05 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-03 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-29 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-05-02 | 8-K | Listing Notice | SEC |
| 2025-02-21 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-02-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-16 | 8-K | Other Events | SEC |
| 2024-12-06 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-11-26 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2024-11-25 | 8-K | Listing Notice | SEC |
| 2024-11-07 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-08-20 | 8-K | Officer / Director Changes, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-08-06 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-07-02 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-13 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-04-10 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-03-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-03-07 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2024-02-02 | 8-K | Auditor Change, Financial Statements & Exhibits | SEC |
| 2024-01-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.